http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28213515

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't
issn 1471-2407
issueIdentifier 1
pageRange 146-
publicationName BMC Cancer
startingPage 146
bibliographicCitation Solares AM, Santana A, Baladrón I, Valenzuela C, González CA, Díaz A, Castillo D, Ramos T, Gómez R, Alonso DF, Herrera L, Sigman H, Perea SE, Acevedo BE, López-Saura P. Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies. BMC Cancer. 2009 May 13;9():146. PMID: 19439079; PMCID: PMC2689241.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_028ef7802bf807382e6631edd70eb442
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5600ec1d0547423b8e31343d43e74a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c96e50ea80fc6df2ae68e9ada1f25ed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fbade4a50a3ebb21d710bff7f3573fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe5e6875e7c20c759000046018e2a5d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb6f12fb6a6879d6942cd3d99b15e882
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_361303f80efb70d2ddc04dbff80adc75
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f54f6ff4dd41694645dac2dc491dfc79
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46a69286fdbede24eda1da956ae05d74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_185fa54039cd728f5bbf79c57d8f8157
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbbfc2b9857893f28fb04e1397d337e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_755ab2081c6a78db68f76a5e3897297d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_970c874b2deeddff930b3b2b6cd4b763
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b146252ebeb0b4d27858d175f4c6f6a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca134185c6d018d00f29344e4b2ea8fe
date 2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19439079
https://doi.org/10.1186/1471-2407-9-146
https://pubmed.ncbi.nlm.nih.gov/PMC2689241
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
title Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
discusses http://id.nlm.nih.gov/mesh/M0016239
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0232027
http://id.nlm.nih.gov/mesh/M0526194
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10389
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_411dabb6f9bf2eafd7e325579645e525
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10738
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7231
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6726
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8537
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7635
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7948
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129978914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127765602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128754351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129071275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129329761

Total number of triples: 59.